Key facts
- This page summarizes Boekhorst Paul Francis Olivier Te's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Nov 2026, 13:54.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Total beneficial ownership shown here reflects a correction in the amount previously reported June 22, 2026 on Form 4 (which correctly reported the number of shares purchases but overstated total ownership by 47 shares).
Footnote F2
The stock option vests in three annual installments of 24.759 shares on the first, second and third anniversaries of the November 7, 2026 grant date. The first installment vested on November7, 2026.
Footnote F3
Represents the number of shares remaining subject to the option following the reported exercise.